KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,393 | -49.3% | 43,700 | -36.1% | 0.00% | -50.0% |
| Q2 2023 | $2,748 | -46.9% | 68,400 | -43.5% | 0.00% | -42.9% |
| Q1 2023 | $5,171 | +17.2% | 121,100 | +31.8% | 0.01% | +16.7% |
| Q4 2022 | $4,413 | -99.9% | 91,900 | -5.5% | 0.01% | +20.0% |
| Q3 2022 | $3,657,000 | -6.6% | 97,200 | -31.4% | 0.01% | 0.0% |
| Q2 2022 | $3,915,000 | +1259.4% | 141,700 | +2573.6% | 0.01% | – |
| Q1 2022 | $288,000 | -70.4% | 5,300 | -78.4% | 0.00% | -100.0% |
| Q3 2021 | $972,000 | +36.5% | 24,572 | +143.3% | 0.00% | 0.0% |
| Q4 2020 | $712,000 | +4.2% | 10,100 | -42.9% | 0.00% | 0.0% |
| Q3 2020 | $683,000 | +189.4% | 17,700 | +181.0% | 0.00% | – |
| Q2 2020 | $236,000 | – | 6,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,412,705 | $99,652,000 | 10.82% |
| CHI Advisors LLC | 433,852 | $30,604,000 | 8.62% |
| VR Adviser, LLC | 672,306 | $47,424,000 | 6.97% |
| Consonance Capital Management LP | 557,095 | $39,297,000 | 3.67% |
| Logos Global Management LP | 450,000 | $31,743,000 | 2.72% |
| RA Capital Management | 1,875,000 | $132,263,000 | 1.85% |
| Nantahala Capital Management | 534,514 | $37,705,000 | 1.17% |
| Orbimed Advisors | 1,679,417 | $118,466,000 | 1.04% |
| Eventide Asset Management | 346,000 | $24,407,000 | 0.37% |
| Atom Investors LP | 49,981 | $3,526,000 | 0.36% |